1. Home
  2. MYSZ vs XRTX Comparison

MYSZ vs XRTX Comparison

Compare MYSZ & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.85

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.56

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
XRTX
Founded
1999
2011
Country
Israel
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MYSZ
XRTX
Price
$0.85
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
276.4K
32.8K
Earning Date
11-14-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,512,000.00
N/A
Revenue This Year
$18.06
N/A
Revenue Next Year
$36.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.51
52 Week High
$3.04
$1.41

Technical Indicators

Market Signals
Indicator
MYSZ
XRTX
Relative Strength Index (RSI) 47.05 45.75
Support Level $0.82 $0.55
Resistance Level $0.88 $0.60
Average True Range (ATR) 0.07 0.03
MACD 0.00 -0.00
Stochastic Oscillator 17.81 30.62

Price Performance

Historical Comparison
MYSZ
XRTX

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: